Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Effect of the Need for Preoperative Dialysis on Perioperative Outcomes on Patients Undergoing Laparoscopic Nephrectomy: An Analysis of the National Surgical Quality Improvement Program Database.

May D, Khaled D, Matrana MR, Bardot SF, Lata-Arias K, Canter D.

Urology. 2019 Feb;124:154-159. doi: 10.1016/j.urology.2018.11.010. Epub 2018 Nov 15.

PMID:
30448368
2.

nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2.

Gajra A, Karim NA, Mulford DA, Villaruz LC, Matrana MR, Ali HY, Santos ES, Berry T, Ong TJ, Sanford A, Amiri K, Spigel DR.

Front Oncol. 2018 Jul 24;8:253. doi: 10.3389/fonc.2018.00253. eCollection 2018.

3.
4.

Building a Phase 1 Cancer Research Program: Lessons Learned and Progress Made.

Matrana MR, Cook J.

Ochsner J. 2017 Winter;17(4):319-321. No abstract available.

5.

Alternative Response Criteria and Clinical Risk Factors for Assessing Tumor Response in Patients With Metastatic Renal Cell Carcinoma Who Are Receiving Salvage Therapy.

Kang HC, Gupta S, Wei W, Lu L, Matrana MR, Tannir NM, Choi H.

AJR Am J Roentgenol. 2017 Dec;209(6):1278-1284. doi: 10.2214/AJR.17.18018. Epub 2017 Oct 24.

6.

Outcomes of Patients With Metastatic Non-Clear-Cell Renal Cell Carcinoma Treated With Pazopanib.

Matrana MR, Baiomy A, Campbell M, Alamri S, Shetty A, Teegavarapu P, Kalra S, Xiao L, Atkinson B, Corn P, Jonasch E, Elsayes KM, Tannir NM.

Clin Genitourin Cancer. 2017 Apr;15(2):e205-e208. doi: 10.1016/j.clgc.2016.07.016. Epub 2016 Jul 22.

PMID:
27568124
7.

An Abundance of Polyps: An Intriguing Case of Lymphomatous Polyposis.

Fox C, Poosarla T, Mandalapu K, Vargas HD, Matrana MR.

J La State Med Soc. 2015 Jul-Aug;167(4):183-5. Epub 2015 Aug 15.

PMID:
27159512
8.

Emerging Immunotargets and Immunotherapies in Prostate Cancer.

Montironi R, Santoni M, Sotte V, Cheng L, Lopez-Beltran A, Massari F, Matrana MR, Moch H, Berardi R, Scarpelli M.

Curr Drug Targets. 2016;17(7):777-82. Review.

PMID:
26898309
9.

Emerging Immunotargets in Bladder Cancer.

Massari F, Ciccarese C, Vau N, Santoni M, Montironi R, Cheng L, Marques RC, Scarpelli M, Fonseca J, Matrana MR, Holger M, Cascinu S, Tortora G, Lopez-Beltran A.

Curr Drug Targets. 2016;17(7):757-70.

PMID:
26844572
10.

Metastatic Prostate Cancer 35 Years After Sex Reassignment Surgery.

Ellent E, Matrana MR.

Clin Genitourin Cancer. 2016 Apr;14(2):e207-9. doi: 10.1016/j.clgc.2015.11.007. Epub 2015 Nov 17. No abstract available.

PMID:
26707953
11.

An Overview of Emerging Immunotargets of Genitourinary Tumors.

Montironi R, Santoni M, Cheng L, Lopez-Beltran A, Massari F, Matrana MR, Moch H, Scarpelli M.

Curr Drug Targets. 2016;17(7):750-6. Review.

PMID:
26648079
12.

Emerging Immunotargets in Metastatic Renal Cell Carcinoma.

Kucharczyk J, Matrana MR, Santoni M, Massari F, Scarpelli M, Cheng L, Lopez-Beltran A, Cascinu S, Montironi R, Holger M.

Curr Drug Targets. 2016;17(7):771-6. Review.

PMID:
26648075
13.

Outcomes of unselected patients with metastatic clear-cell renal cell carcinoma treated with first-line pazopanib therapy followed by vascular endothelial growth factor receptor tyrosine kinase inhibitors or mammalian target of rapamycin inhibitors: a single institution experience.

Matrana MR, Bathala T, Campbell MT, Duran C, Shetty A, Teegavarapu P, Kalra S, Xiao L, Atkinson B, Corn P, Jonasch E, Tannir NM.

BJU Int. 2016 Aug;118(2):264-71. doi: 10.1111/bju.13374. Epub 2015 Dec 13.

14.

BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies.

Piva F, Santoni M, Matrana MR, Satti S, Giulietti M, Occhipinti G, Massari F, Cheng L, Lopez-Beltran A, Scarpelli M, Principato G, Cascinu S, Montironi R.

Expert Rev Mol Diagn. 2015;15(9):1201-10. doi: 10.1586/14737159.2015.1068122. Epub 2015 Jul 11. Review.

PMID:
26166446
15.

Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases.

Kalra S, Atkinson BJ, Matrana MR, Matin SF, Wood CG, Karam JA, Tamboli P, Sircar K, Rao P, Corn PG, Tannir NM, Jonasch E.

BJU Int. 2016 May;117(5):761-5. doi: 10.1111/bju.13185. Epub 2015 Jul 6.

16.

Outcomes of Adults With Ewing Sarcoma Family of Tumors (ESFT) of the Kidney: A Single-Institution Experience.

Teegavarapu PS, Rao P, Matrana MR, Cauley DH, Wood CG, Patel S, Tannir NM.

Am J Clin Oncol. 2017 Apr;40(2):189-193. doi: 10.1097/COC.0000000000000128.

17.

Renal medullary carcinoma: a case report and brief review of the literature.

Shetty A, Matrana MR.

Ochsner J. 2014 Summer;14(2):270-5.

18.

Outcomes of patients with metastatic renal cell carcinoma and end-stage renal disease receiving dialysis and targeted therapies: a single institution experience.

Shetty AV, Matrana MR, Atkinson BJ, Flaherty AL, Jonasch E, Tannir NM.

Clin Genitourin Cancer. 2014 Oct;12(5):348-53. doi: 10.1016/j.clgc.2014.01.004. Epub 2014 Jan 18.

19.

Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with pazopanib after disease progression with other targeted therapies.

Matrana MR, Duran C, Shetty A, Xiao L, Atkinson BJ, Corn P, Pagliaro LC, Millikan RE, Charnsangave C, Jonasch E, Tannir NM.

Eur J Cancer. 2013 Oct;49(15):3169-75. doi: 10.1016/j.ejca.2013.06.003. Epub 2013 Jun 26.

20.

Screening for prostate cancer: the debate continues.

Matrana MR, Atkinson B.

J Adv Pract Oncol. 2013 Jan;4(1):16-21. Review.

21.

Chromophobe renal cell carcinoma with sarcomatoid dedifferentiation treated with pazopanib: a case report.

Matrana MR, Ng C, Rao P, Lim ZD, Tannir NM.

Clin Genitourin Cancer. 2011 Dec;9(2):137-9. doi: 10.1016/j.clgc.2011.06.005. Epub 2011 Aug 10. No abstract available.

PMID:
21831725
22.

Emerging targeted therapies in metastatic renal cell carcinoma.

Matrana MR, Atkinson B, Jonasch E, Tannir NM.

Curr Clin Pharmacol. 2011 Aug;6(3):189-98. Review.

PMID:
21827388
23.

Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions.

Chowdhury S, Matrana MR, Tsang C, Atkinson B, Choueiri TK, Tannir NM.

Hematol Oncol Clin North Am. 2011 Aug;25(4):853-69. doi: 10.1016/j.hoc.2011.05.003. Review.

24.

Severe hypokalemia and hematuria: a case of Munchausen's syndrome.

Matrana MR, McDonald PF, Rostlund E.

J La State Med Soc. 2011 Jan-Feb;163(1):21-5. No abstract available.

PMID:
21675002
25.

Epidemiology and pathophysiology of diverticular disease.

Matrana MR, Margolin DA.

Clin Colon Rectal Surg. 2009 Aug;22(3):141-6. doi: 10.1055/s-0029-1236157.

26.

Paralysis and pernicious anemia in a young woman.

Matrana MR, Gauthier C, Lafaye KM.

J La State Med Soc. 2009 Jul-Aug;161(4):228-32.

PMID:
19785315
27.

Vitamin deficiency after gastric bypass surgery: a review.

Matrana MR, Davis WE.

South Med J. 2009 Oct;102(10):1025-31. doi: 10.1097/SMJ.0b013e3181b62614. Review.

PMID:
19738526
28.

The skinny on a growing problem: dry beriberi after bariatric surgery.

Matrana MR, Vasireddy S, Davis WE.

Ann Intern Med. 2008 Dec 2;149(11):842-4. No abstract available.

PMID:
19047041

Supplemental Content

Loading ...
Support Center